News & Insights
Llusern at ECCMID23 in Copenhagen
Dr Emma Hayhurst will be presenting the latest data from Llusern’s work in developing fast and accurate point-of-care UTI testing…
Women feel ‘failed’ by UTI testing system – ITV News
Llusern was delighted to be asked to contribute to a report by ITV News reporter Stacey Foster on chronic UTIs.…
Llusern included in NICE early value assessment for UTI testing
Llusern Scientific is delighted to be included as one of the point-of-care technologies being considered by the National Institute for…
Llusern win at MediWales Awards 2022
Emma and Jeroen accept the Partnership with the NHS Award Last Thursday we were thrilled to win the ‘Partnership with…
Radio 4’s Woman’s Hour talk UTIs with Llusern
https://www.bbc.co.uk/sounds/play/m001fn3p Last Friday BBC Radio 4’s Woman’s Hour invited Emma Hayhurst onto the programme to talk about Urinary Tract Infections…
Llusern wins at the Wales STEM Awards
CSO Jeroen Nieuwland (back row, fourth from the right) with the Innovation Award Llusern Scientific were delighted to be the…
UTI test undergoing clinical verification and validation
Llusern are pleased and proud to be working with the Bevan Commission to tackle the problem of UTIs. Llusern, in…
CEO awarded top prize to develop UTI test
Llusern Scientific CEO and co-founder, Dr Emma Hayhurst, has been awarded the Innovation Prize from ‘Women in Innovation’. With nearly…
Start a conversation with Llusern
Llusern is developing treatment-directing diagnostics for high-volume healthcare challenges, starting with rapid molecular UTI testing. To learn more about the company, the product and the opportunity ahead, speak to the Llusern team.